✦ LIBER ✦

Age, outcomes, and treatment effects of fibrinolytic and antithrombotic combinations: Findings from Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT)-3 and ASSENT-3 PLUS

✍ Scribed by Peter R. Sinnaeve; Yao Huang; Kris Bogaerts; Alec Vahanian; Jennifer Adgey; Paul W. Armstrong; Lars Wallentin; Frans J. Van de Werf; Christopher B. Granger

Book ID: 116190684
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 310 KB
Volume: 152
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2006.07.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Refining clinical trial composite outcom

Refining clinical trial composite outcomes: An application to the Assessment of the Safety and Efficacy of a New Thrombolytic–3 (ASSENT-3) trial

✍ Paul W. Armstrong; Cynthia M. Westerhout; Frans Van de Werf; Robert M. Califf; R 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 537 KB

The assessment of the safety and efficac

The assessment of the safety and efficacy of a new thrombolytic regimen (assent)-3 investigators. efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the assent-3 randomized trial in acute myocardial infarction

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Economic analysis of the Assessment of t

Economic analysis of the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT-3) study: Costs of reperfusion strategies in acute myocardial infarction

✍ Padma Kaul; Paul W. Armstrong; Patricia A. Cowper; Eric L. Eisenstein; Christoph 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 251 KB

Unraveling the spectrum of left bundle b

Unraveling the spectrum of left bundle branch block in acute myocardial infarction: Insights from the Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT 2 and 3) trials

✍ Hussam Al-Faleh; Yuling Fu; Galen Wagner; Shaun Goodman; Elena Sgarbossa; Christ 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Efficacy and safety of tenecteplase in c

Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the assessment of the safety and efficacy of a new thrombolytic regimen (ASSENT) 3 plus randomized trial in acute myocardial infarction

✍ L. Wallentin; P. Goldstein; P.W. Armstrong 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Effect of tenecteplase versus alteplase

Effect of tenecteplase versus alteplase on platelets during the first 3 hours of treatment for acute myocardial infarction: The Assessment of the Safety and Efficacy of a New Thrombolytic Agent (ASSENT-2) platelet substudy

✍ Victor L. Serebruany; Alex I. Malinin; Kevin P. Callahan; Azan Binbrek; Frans Va 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 149 KB